Diabetes Mellitus Clinical Trial
— EMSODOfficial title:
Effect of Prolonged Mental Stress During Safe Driving Training Courses on Glucose Control in Patients With Diabetes Mellitus Type 2
Verified date | February 2012 |
Source | University Hospital, Basel, Switzerland |
Contact | n/a |
Is FDA regulated | No |
Health authority | Switzerland: Ethikkommission |
Study type | Interventional |
Introduction Stress is part of the investigators daily life, and means to cope with it allow
adaptation and survival. To this end, physiological pathways are activated, including
neuroendocrine, cardiovascular and metabolic responses. In short term, the majority of
consequences are beneficial, in the long run, however, chronic psychosocial stress may
constitute an increased risk for coronary heart disease, type 2 diabetes, and disability.
Acute mental stress induces an exaggerated release of stress hormones e.g. catecholamine and
cortisol which are thought not only to increase heart rate (HR) and blood pressure (BP) but
also to increase blood glucose levels. In clinical practice, patients and health care
providers are often confronted with questions concerning psychological stress as a possible
reason for glucose fluctuations. Whether stress itself or poor treatment adherence is
responsible for the altered glucose control remains often controversial. Differences in the
inter- and intraindividual response to stress have been suggested, but only a few small
studies have addressed the effect of acute psychological stress on glucose control in
patients with diabetes. Patients with type 2 diabetes may overestimate the effect of acute
psychological stress on glucose control but further studies are clearly needed to definitely
exclude or confirm a relevant effect of stress on the glucose control in diabetic patients.
For example, effects of longer lasting or repetitive events of psychological stress on
glucose concentrations still remain elusive. The aim of the present study was therefore to
investigate the effect of prolonged psychological stress by means of repetitive safe driving
training courses on glucose control in patients with diabetes.
Patients and Methods Forty patients with type 1 or insulin-treated type 2 diabetes attending
the outpatient-clinic of the Kantonsspital Frauenfeld or University Hospital of Zurich for
regular visits are invited to participate. Included are patients on any oral
glucose-lowering treatment and at least one daily injection of insulin, a valid driver
license and written informed consent given. Exclusion criteria are diabetes duration <2
years, pregnancy, unstable coronary artery disease, limited visual acuity or unstable
proliferative diabetic retinopathy, uncontrolled hypertension (BP >160/95mmHg) and pituitary
or adrenal disease. The Ethics committee of the Kanton Thurgau approved the protocol and the
study conform to the principles outlined in the Declaration of Helsinki.
Study protocol Each patient completes a control and a stress testing day which takes place
consecutively in a randomized order. Randomization is performed by an uninvolved third
person. The study is carried out at the driving training area of the Touring Club
Switzerland at Hinwil. Patients are advised to have lunch before 12:00 a.m. and to abstain
from food thenceforth. Drinking mineral water remains allowed during the entire study days,
and the patients have to take their basal insulin and other medication as usual. Patients
are advised to arrive at the driving training area between 2:30 and 3:00 p.m. At arrival, a
capillary glucose measurement is carried out, and glucose concentrations ≥10mmol/l are
corrected with short-acting insulin analogues (glucose target 6 - 8mmol/l). Subsequently, no
additional adjustment with insulin is allowed during the study. Glucose concentrations
≤4mmol/l are always corrected with administration of 10g carbohydrate (DextroEnergy® or
orange juice). On both study days, patients ingest a standard meal at 4:45 p.m. (i.e. 15min
before the driving training). Immediately after the meal, short-acting insulin is injected
in knowledge of the carbohydrate content (same dose on both days) or oral antidiabetics are
ingested as usual. Measurements of capillary and plasma glucose concentration, blood
pressure, heart rate, stress perception and salivary cortisol concentration are carried out
in regular intervals between 4 and 9 p.m. on both study days.
On the control day, patients are placed in a quiet room and are permitted to read. They also
have the possibility to leave the room and stay on a balcony.
On the stress testing day, patients complete a driving training with their car between 5 and
7 p.m. The driving training consists of 3 consecutive exercises: first, a slalom track on
dry and wet asphalt, secondly, a full braking exercise with water obstacles. Thirdly, the
car is hurled around by a mechanical plate and the patients has to regain control over it.
Status | Completed |
Enrollment | 40 |
Est. completion date | November 2011 |
Est. primary completion date | November 2011 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - diabetes mellitus type 1 and type 2 - stable glucose control - valid driver license - written informed consent Exclusion Criteria: - pregnancy - unstable coronary artery disease - limited visual acuity or unstable proliferative diabetic retinopathy - uncontrolled hypertension (BP >160/95mmHg). |
Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Basic Science
Country | Name | City | State |
---|---|---|---|
Switzerland | Kantonsspital Frauenfeld | Frauenfeld |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Basel, Switzerland | Kantonsspital Frauenfeld |
Switzerland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Mean and maximum change from baseline in glucose level (mmol/l) | Glucose level will be measured before and every 15-30 minutes after stress application for up to 240 minutes | within 240 minutes after stress | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03743779 -
Mastering Diabetes Pilot Study
|
||
Completed |
NCT03786978 -
Pharmaceutical Care in the Reduction of Readmission Rates in Diabetes Melitus
|
N/A | |
Completed |
NCT01804803 -
DIgital Assisted MONitoring for DiabeteS - I
|
N/A | |
Completed |
NCT05039970 -
A Real-World Study of a Mobile Device-based Serious Health Game on Session Attendance in the National Diabetes Prevention Program
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT04068272 -
Safety of Bosentan in Type II Diabetic Patients
|
Phase 1 | |
Completed |
NCT03243383 -
Readmission Prevention Pilot Trial in Diabetes Patients
|
N/A | |
Completed |
NCT03730480 -
User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS)
|
N/A | |
Recruiting |
NCT02690467 -
Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm.
|
N/A | |
Completed |
NCT02229383 -
Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus
|
Phase 3 | |
Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
Completed |
NCT06181721 -
Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes
|
N/A | |
Recruiting |
NCT04489043 -
Exercise, Prediabetes and Diabetes After Renal Transplantation.
|
N/A | |
Withdrawn |
NCT03319784 -
Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic Patients
|
Phase 4 | |
Completed |
NCT03542084 -
Endocrinology Auto-Triggered e-Consults
|
N/A | |
Completed |
NCT02229396 -
Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo
|
Phase 3 | |
Recruiting |
NCT05544266 -
Rare and Atypical Diabetes Network
|
||
Completed |
NCT01892319 -
An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
|
||
Completed |
NCT05031000 -
Blood Glucose Monitoring Systems: Discounter Versus Brand
|
N/A | |
Recruiting |
NCT04039763 -
RT-CGM in Young Adults at Risk of DKA
|
N/A |